Blockade of CD73 with MEDI9447 increased the infiltration of several immune cell populations, such as CD8+ T cells and activated macrophages, into the cancer niche with synergic activity upon its combined administration with anti-PD-1 antibodies, further supporting the potential value of relieving adenosine-mediated immunosuppression. Here, NT5E is linked to cancer.